AJCC Cancer Staging Manual

SKU: 9783319406176
Regular price $250.00
Unit price
per
  • Author:
    Various
  • ISBN:
    9783319406176
  • Publication Date:
    November 2017
  • Edition:
    10
  • Pages:
  • Binding:
    Hardback
  • Publisher:
    Palgrave-Springer
  • Country of Publication:
    Switzerland
AJCC Cancer Staging Manual
AJCC Cancer Staging Manual

AJCC Cancer Staging Manual

SKU: 9783319406176
Regular price $250.00
Unit price
per
  • Author:
    Various
  • ISBN:
    9783319406176
  • Publication Date:
    November 2017
  • Edition:
    10
  • Pages:
  • Binding:
    Hardback
  • Publisher:
    Palgrave-Springer
  • Country of Publication:
    Switzerland

Description

The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neoplastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.

(0 in cart)
Shipping calculated at checkout.
This is a Sample Product Title
Was $200.00 Now $100.00

You may also like

  • The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neoplastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.

The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neoplastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.